BioCentury
ARTICLE | Company News

Alltracel, HemCon deal

May 19, 2008 7:00 AM UTC

Medical device company HemCon completed its previously announced acquisition of Alltracel for 14p per share, or £20.8 million ($40.6 million) in cash (see BioCentury, March 3). ...